SEC FORM 4
—
Mirum Pharmaceuticals, Inc. (MIRM)
Acquisition (code M) of 18,333 shares; price not stated (see filing).
Reporting Person BJERKHOLT ERIC · Officer Title CHIEF FINANCIAL OFFICER · Transaction Code M
Traded Sep 11, 2026 · Disclosed Sep 15, 2026
Source: SEC Form 4 · 0001197350-26-000010 · filed 2026-09-15 · View filing →